PIN9 COST-EFFECTIVENESS ANALYSIS OF COMBINED THERAPY WITH PEGINTERFERON ALFA-2A (40KD) (PEGASYS) AND RIBAVIRIN (COPEGUS) IN PATIENTS WITH CHRONIC C HEPATITIS (CHC) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) CO-INFECTION
Abstract
Authors
C Rubio Terres C Alvarez Sanz K Patel